Ebb & Flow

For small companies with constrained options in the current financing environment, alternative approaches tied to royalty or revenue interests continue to be the order of the day. Last week, a trio of alternative vehicles went through, two revenue interest financings, one by Paul Capitaland another by Deerfield Capital, and a royalty financing by Deerfield.

Genitourinary company Plethora (LSE:PLE) signed a $25 million revenue interest financing with Paul Capital, with an option for an additional $3 million equity investment...